Skip to main content

Diametric Capital, LP

SEC CIK
0001719087
Latest filing
Aug 14, 2026

MGX holding history

Metagenomi Therapeutics, Inc. in every 13F filed by Diametric Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MGX overviewAll 13F holders of MGXFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2024
Holdings of MGX by Diametric Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−49,285−100.0%Sold outHolders
Q1 202549,285$67.0K0.1%+7,670+18.4%AddedHolders
Q4 202441,615$150.2K0.1%+41,615NewHolders